Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 3 5Phase 2 3Phase 1/2 1

Status

Terminated 2Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5Other 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 8Neoplasms 5Lung Neoplasms 5Head and Neck Neoplasms 5Leukemia, Myeloid, Acute 4Hematologic Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Pulmonary Disease, Chronic Obstructive 2Neoplasm Metastasis 2Lymphoma, Follicular 2Leukemia 2Colonic Neoplasms 2COVID-19 2Xerostomia 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Teratoma 1Stroke 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1

Interventions

Cisplatin 47Radiotherapy 37Fluorouracil 23Cetuximab 17pembrolizumab 11Carboplatin 11Paclitaxel 8Docetaxel 8Radiotherapy, Intensity-Modulated 6Chemotherapy, Adjuvant 6Surgical Procedures, Operative 5Standard of Care 5nimotuzumab 4Methotrexate 4Gabapentin 4Drug Therapy 4Afatinib 4Radiotherapy, Conformal 3Radiation 3Porfiromycin 3Nivolumab 3Neoadjuvant Therapy 3Fibroblast Growth Factor 7 3Bleomycin 3zalutumumab 2sargramostim 2epacadostat 2Tranexamic Acid 2Tirapazamine 2Pilocarpine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Head and Neck Neoplasms × Standard of Care × Clear all
NCT01266044 2026-04-16

Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
435 enrolled
Head & Neck

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Xerostomia

NCT02369874 2021-02-10

EAGLE

AstraZeneca

Phase 3 Completed
736 enrolled 26 charts
Head & Neck

Head and Neck Neoplasms, Recurrence

NCT01917942 2017-07-12

RadioHum

Trans Tasman Radiation Oncology Group

Phase 3 Completed
210 enrolled
Head & NeckOther

Head and Neck Neoplasms, Mucositis

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Hoffmann-La Roche

Phase 3 Terminated
94 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms

NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Endo Pharmaceuticals

Phase 3 Terminated
240 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡